XORTX Therapeutics Inc.

TSXV:XRTX Stock Report

Market Cap: CA$5.4m

XORTX Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:XRTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Apr 25BuyCA$3,860Allen DavidoffIndividual3,000CA$1.29
15 Apr 25BuyCA$3,810Allen DavidoffIndividual3,000CA$1.27
28 Feb 25BuyCA$4,712Allen DavidoffIndividual3,100CA$1.52
14 Feb 25BuyCA$11,235Allen DavidoffIndividual8,500CA$1.36
07 Feb 25BuyCA$6,080Allen DavidoffIndividual4,500CA$1.36
23 Jan 25BuyCA$3,399Allen DavidoffIndividual2,500CA$1.36
16 Jan 25BuyCA$14,900Allen DavidoffIndividual10,000CA$1.49
20 Dec 24BuyCA$1,630Allen DavidoffIndividual1,000CA$1.63
02 Oct 24BuyCA$9,292Allen DavidoffIndividual4,300CA$2.17
16 Sep 24BuyCA$719Allen DavidoffIndividual300CA$2.40
28 Aug 24BuyCA$1,590Allen DavidoffIndividual1,000CA$1.59
09 Aug 24BuyCA$4,582Allen DavidoffIndividual2,000CA$2.32
05 Jul 24BuyCA$2,463Allen DavidoffIndividual1,000CA$2.46

Insider Trading Volume

Insider Buying: XRTX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of XRTX?
Owner TypeNumber of SharesOwnership Percentage
Institutions21,9640.58%
Individual Insiders135,8383.59%
Hedge Funds346,8079.15%
General Public3,283,63786.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 30.7%.

Top Shareholders

Top 10 shareholders own 13.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.15%
Armistice Capital LLC
346,807CA$495.9k104%0.01%
2.96%
Allen Davidoff
112,157CA$160.4k44.6%no data
0.46%
UBS Asset Management AG
17,428CA$24.9k-7.2%no data
0.25%
Anthony Giovinazzo
9,625CA$13.8k0%no data
0.19%
Paul Van Damme
7,110CA$10.2k0%no data
0.18%
James Fairbairn
6,946CA$9.9k0%no data
0.043%
National Bank Investments Inc.
1,613CA$2.3k-53.1%no data
0.039%
RBC Dominion Securities Inc., Asset Management Arm
1,493CA$2.1k122%no data
0.03%
Osaic Wealth, Inc. , Asset Management Arm
1,153CA$1.6k0%no data
0.0073%
Clearstead Advisors, LLC
277CA$396.00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 22:26
End of Day Share Price 2025/05/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

XORTX Therapeutics Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners